Natus Launches AI-Powered autoSCORE Tool for EEG Devices, Transforming Neurodiagnostics
Published: 12 Mar 2026
Author: Precedence Research
Global launch of autoSCORE AI analysis tool, making a step to define a moment for the neurodiagnostics field. U.S. neuro care teams are meeting the demands on clinical resources to experience the benefits of autoscore. Natus NeuroWorks software autoSCORE is FDA 510(k) cleared for the indication to include routine EEG, LTM, and Ambulatory EEG studies, and it has received the CE mark for European and other markets.
AI in clinical EEGs
Chris Landon, CEO of Natus Neuro, said, It is the first AI model capable of interpreting clinical EEGs and a defining moment for both Natus and the field of neurodiagnostics. It was a very proud moment and a breakthrough innovation in healthcare. With the advancement in technology and mission, patient has got access and deliver life-changing outcomes.
The company has started adopting AI in early stage, assessing multiple clinically relevant abnormalities and providing study-level assessments to inform healthcare providers whether the EEG study is normal or abnormal.
Dr. Ram Mohan Sankaraneni, a board-certified neurologist and member of the American Academy of Neurology, provided a second opinion as a powerful pathway for faster intervention: ‘’Human teaming with intelligent machines has become a fundamental characteristic of a successful clinical decision support system.’’
According to Toward Healthcare, the neurodiagnostics market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 20.68 billion in 2026 to approximately USD 43.27 billion by 2035, representing a compound annual growth rate (CAGR) of 5.52% from 2026 to 2035. It shows benefits in the analysis tool, spreading the availability of the first artificial-intelligence model as it is capable of automatic and comprehensive clinical EEG interpretations, also providing accuracy with medical experts.
About Natus
Natus provide global solutions and is also a trusted partner of healthcare services source to screen, diagnose and provide treatment to disorders affecting the brain and neural pathways.
Natus provide solutions which include service, field support and education, enabling clinicians to advance their standard of care, improving patient outcomes and quality of life.
A recent report by Toward Healthcare highlights that the neurodiagnostics market, with continuous innovation in EEG technology, including wireless, portable devices and AI-powered diagnostic tools, improves ease of use, accuracy, and efficiency, analysis tool, spreading the availability of the first artificial-intelligence model capable of automatic and comprehensive clinical EEG interpretations while providing accuracy on par with medical experts.